Saturday, November 2, 2024
HomeTagsTecentriq Plus Avastin

Tecentriq Plus Avastin

Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study

Genentech, a member of the Roche Group, announced new data from the Phase III IMbrave050 study that show Tecentriq plus Avastin demonstrated a statistically significant...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics